NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CECO Environmental Corp. (“CECO” or the “Company”) (NASDAQ: CECO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Tag: PR Newswire
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Quantum Computing, Inc. (“Quantum Computing” or the “Company”) (NASDAQ: QUBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Red Cat Holdings, Inc. (“Red Cat” or the “Company”) (NASDAQ: RCAT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NASDAQ: HII). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. (“Keros” or the “Company”) (NASDAQ: KROS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson. (“J&J” or the “Company”) (NYSE: JNJ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sezzle Inc. (“Sezzle” or the “Company”) (NASDAQ: SEZL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. (“4D” or the “Company”) (NASDAQ: FDMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Midland States Bancorp, Inc. (“Midland States Bancorp” or the “Company”) (NASDAQ: MSBI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,…